MAYZENT .25 mg/1 (Siponimod TABLET, FILM COATED) .25 mg/1

MAYZENT .25 mg/1 is a prescription medication containing siponimod, used to manage specific medical conditions. This oral tablet is designed for precise therapeutic use, offering a convenient treatment option.

Strength

.25 mg/1

Pack Size

28 TABLET, FILM COATED in 1 BOTTLE (0078-0979-92)

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

MAYZENT .25 mg/1, containing the active ingredient siponimod, is primarily used for managing certain autoimmune conditions. This medication is often prescribed to help control symptoms and improve quality of life. Patients may wonder, 'What is MAYZENT used for?' It is typically utilized in conditions where immune system modulation is beneficial.

Side Effects

Common effects of MAYZENT .25 mg/1 may include mild to moderate side effects such as headache, fatigue, and gastrointestinal discomfort. These effects vary among individuals and are generally manageable. Patients should consult their healthcare provider for personalized advice.

Precautions & Warnings

MAYZENT .25 mg/1 should be handled with care, following the prescribed dosage and administration guidelines. It is important to store the medication as directed and to inform your healthcare provider about any pre-existing conditions or allergies. Always follow the advice of a healthcare professional.

Avoid Interactions

MAYZENT .25 mg/1 may interact with certain medications, including those that affect the immune system or are metabolized by specific liver enzymes. Alcohol and other substances may also influence its effectiveness. Patients should discuss all current medications with their healthcare provider to avoid potential interactions.

Frequently Asked Questions

MAYZENT .25 mg/1 is used to manage specific autoimmune conditions by modulating the immune system.

MAYZENT .25 mg/1 is taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects may include headache, fatigue, and gastrointestinal discomfort.

Patients should consult their healthcare provider before taking MAYZENT .25 mg/1 with other medications to avoid potential interactions.

Long-term use of MAYZENT .25 mg/1 should be monitored by a healthcare provider to ensure safety and effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.